Adjuvant strategies in breast cancer: New prospectives, questions and reflections at the end of 2007 St Gallen International Expert Consensus Conference

Annals of Oncology

Volumn 18, Issue SUPPL. 6, 2007, Pages

  Cinieri, Saverio ^a,b   Orlando, L ^b   Fedele, P ^a   Cusmai, A ^a   D'Amico, M ^a   Rizzo, P ^a   Chetri, M C ^a  

^a Medical Oncology Division   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Adjuvant treatment; Breast cancer; St Gallen Consensus Conference

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; AROMATASE INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CARBOPLATIN; COLECALCIFEROL; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUOROURACIL; GONADORELIN DERIVATIVE; HEMOPOIETIC GROWTH FACTOR; METHOTREXATE; PLATINUM COMPLEX; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

ADJUVANT THERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER REGRESSION; CHROMOSOME 17; CLINICAL DECISION MAKING; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DISEASE FREE SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT SELECTION; POSTMENOPAUSE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; DRUG ANTAGONISM; EXPERT WITNESS; FEMALE; METABOLISM; METHODOLOGY; REVIEW;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CONSENSUS DEVELOPMENT CONFERENCES; EXPERT TESTIMONY; FEMALE; HUMANS; RECEPTOR, ERBB-2;

EID: 35748957193     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm227     Document Type: Conference Paper

References (0)